Alerts

Stryker is conducting a Critical Product Correction of Pad-Paks used with the HeartSine samaritan Public Access Defibrillator (PAD), with an expiry date range between 17 April 2025 to 01 August 2029.

Product correction and Product alert. This update includes new information regarding the software correction, actions for healthcare professionals and inclusion of the single chamber (SR) pacemaker.

We continue to receive reports of lead poisoning linked to imported or unregistered Ayurvedic medicines contaminated with heavy metals.

Pharmacists can dispense 200 mg tablets during the shortage.

Grace & Fire Pty Ltd (trading as Ultra Violette) is recalling all batches of Ultra Violette Lean Screen SPF 50+ due to inconsistency in the SPF level of the product.

Star Combo Australia Pty Ltd is recalling multiple batches of four Living Healthy High Strength Gummies products due to non-compliant labelling.

Product Alert: Australasian Medical & Scientific Ltd (AMSL), the sponsor of the t:slim X2 insulin pump, has identified that certain versions of the device have a wiring problem with the speaker.

Using a home-use foetal heart monitor to check a baby’s heartbeat may seem reassuring but it can be dangerously misleading. We have received reports of instances where they have provided false reassurance, leading to delayed medical attention and infant deaths.

Invacare Australia is updating the Instructions for Use (IFU) of the Birdie Lifter and Compact Lifter. Users need to be aware of the correct position for the carabiner and the correct attachment of the hanger bar.

Homart Pharmaceuticals Pty Ltd is recalling specific batches of its product, SpringLeaf Fat Clear, due to two identified compliance problems.

Concerta modified-release tablets will remain in shortage at various times until the end of 2026

Consumers and health professionals should be aware that two unrelated cases of counterfeit injectable botulinum toxin products have been stopped at the Australian border.

Well Herb is recalling batch numbers: DB0014M & DB0015M with expiry Date 11/12/2027 supplied in Australia of Xinyi Biyan Pills due to the medicine having unacceptable amounts of lead above the permitted daily dose.

Due to ongoing problems with their A30 and A40 series BiPAP devices, Philips is now contacting those affected to organise replacement devices or discuss alternative options.

All strengths of the Mounjaro vial presentation are discontinued but the Mounjaro KwikPen is available in the same strengths.

Consumers and health professionals should be aware that examples of counterfeit products have been stopped at the Australian border. These tablets may pose a serious risk to your health and should not be used.

Clinical guidance for prescribers during the shortages is available.

Stryker is conducting an Urgent Recall of certain serial numbers of the HeartSine Defibrillators.

Consumers and health professionals should be aware that examples of counterfeit Roche labelled products have been stopped at the Australian border.

Consumers and health professionals should be aware that examples of substandard Fitaro semaglutide pre-filled syringes have been stopped at the Australian border.

The Therapeutic Goods Administration are continuing to see imports of counterfeit ivermectin.

Nhan Sam Tuyet Lien Truy Phong Hoan capsules pose a serious risk to your health and should not be taken.

Pentavite Pty Ltd is recalling two batches of Pentavite Multivitamin + Iron Kids Chewables because the product is missing required warning statements on the label.

We have approved overseas-registered substitutes for Pegasys 135 micrograms/0.5 mL and 180 micrograms/0.5 mL pre-filled syringes.

Product Correction: Some K Care Seat Walkers have been supplied without a complete User Manual.